Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

NCT03734640 is registered in ClinicalTrials.gov with Craig Anderson as lead sponsor.

NCT NCT03734640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03734640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Post Tpa-Iv Monitoring in Ischemic Stroke
Lead sponsor
Craig Anderson
Phase
Not applicable
Overall status
Completed
Start date
April 28, 2021
Completion date
January 23, 2025
Enrollment
4,922 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke patients receiving reperfusion therapy